These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3679306)

  • 21. Radioisotopic assay of lecithin: cholesterol acyltransferase (LCAT) in alcoholic liver diseases: effects of alcohol withdrawal in the LCAT activity.
    Pisculli M; Di Giovanni MG
    Panminerva Med; 1987; 29(4):303-6. PubMed ID: 3431890
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma lecithin: cholesterol acyltransferase activity in liver disease.
    Horii K; Adachi Y; Yamamoto T
    Gastroenterol Jpn; 1979 Dec; 14(6):584-95. PubMed ID: 230993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma lipids and acyltransferase activities in experimental nephrotic syndrome.
    Sestak TL; Alavi N; Subbaiah PV
    Kidney Int; 1989 Aug; 36(2):240-8. PubMed ID: 2779094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dependence of serum lipid and lecithin: cholesterol acyltransferase levels on physical training in young men.
    Marniemi J; Dahlström S; Kvist M; Seppänen A; Hietanen E
    Eur J Appl Physiol Occup Physiol; 1982; 49(1):25-35. PubMed ID: 7201926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in the rate of lecithin cholesterol acyltransferase reaction and lipid indicators of serum under the effect of cathergene in acute experimental liver damage].
    Gaskina TK; Kurilovich SA; Gorchakov VN
    Vopr Med Khim; 1989; 35(4):24-8. PubMed ID: 2815674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cholesterol, free cholesterol, HDL, LDL, triglycerides, LCAT. Evaluation of some risk factors for cardiovascular diseases].
    Andreoli D; Lattuada L; Giovanelli E; Persico D
    Quad Sclavo Diagn; 1982 Jun; 18(2):127-31. PubMed ID: 7167633
    [No Abstract]   [Full Text] [Related]  

  • 27. [LCAT (lecithin:cholesterol acyltransferase)].
    Kinoshita M; Teramoto T
    Rinsho Byori; 2001 Nov; Suppl 116():125-30. PubMed ID: 11797372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substrate specificity of plasma lecithin: cholesterol acyltransferase in abetalipoproteinemia.
    Holmquist L; Carlson LA; Lloyd JK
    Acta Med Scand; 1988; 224(2):135-9. PubMed ID: 3421144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Significance of lecithin-cholesterol acyltransferase analysis in clinical tests].
    Itakura H
    Nihon Rinsho; 1989 Dec; 48 Suppl():564-7. PubMed ID: 2621951
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatic secretion and turnover of serum phosphatidylcholine-cholesterol acyltransferase in male and female rats.
    Soler-Argilaga C; Russell RL; Goh EH; Heimberg M
    Biochim Biophys Acta; 1977 Jul; 488(1):69-75. PubMed ID: 889860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of smoking on serum lipid and lipoprotein concentrations and lecithin: cholesterol acyltransferase activity.
    Dirican M; Sarandöl E; Ulukaya E; Tokullugil HA
    J Med Invest; 1999 Aug; 46(3-4):169-72. PubMed ID: 10687311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lipid-mobilizing effect of reduced glutathione and its intensifying action on lecithin-cholesterol acyltransferase activity in blood serum of rats].
    Sokolik VV
    Ukr Biokhim Zh (1999); 2004; 76(5):66-70. PubMed ID: 16100899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of heparin on lecithin: cholesterol acyltransferase and lipids in cholestasis.
    Rubiés-Prat J; Ras MR; Frisón JC; Miquel C; Masdeu S; Bacardi R
    Digestion; 1976; 14(3):250-5. PubMed ID: 955331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lecithin-cholesterol acyltransferase (LCAT)].
    Itakura H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():82-5. PubMed ID: 15658268
    [No Abstract]   [Full Text] [Related]  

  • 35. Complete deficiency of plasma lecithin-cholesterol acyltransferase (LCAT) activity due to a novel homozygous mutation (Gly-30-Ser) in the LCAT gene.
    Owen JS; Wiebusch H; Cullen P; Watts GF; Lima VL; Funke H; Assmann G
    Hum Mutat; 1996; 8(1):79-82. PubMed ID: 8807342
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipoproteins, HDL-apolipoproteins, activities of hepatic lipase and lecithin-cholesterol acyltransferase in the plasma of patients with post-alcoholic end-stage liver cirrhosis.
    Breier C; Lisch HJ; Braunsteiner H
    Klin Wochenschr; 1983 Sep; 61(18):929-31. PubMed ID: 6632732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lecithin cholesterol acyltransferase (LCAT) and lipid cardiovascular risk factors in hemodialysis patients].
    Sassolas A; Courboules P; Leitienne P; Quincy C; Galland R; Traeger J
    Nephrologie; 1987; 8(5):267-72. PubMed ID: 3444496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of hemosorption repeated three times on activity of lecithin cholesterol acyltransferase].
    Fortinskaia ES; Torkhovskaia TI; Nalivaĭko ES; Kliuchnikova ZhI; Khalilov EM
    Vopr Med Khim; 1989; 35(2):109-12. PubMed ID: 2741406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lecithin:cholesterol acyl transfer in plasma of normal persons in relation to lipid and lipoprotein concentration.
    Wallentin L; Vikrot O
    Scand J Clin Lab Invest; 1975 Nov; 35(7):669-76. PubMed ID: 174186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lecithin:cholesterol acyltransferase activity in relation to lipoprotein concentration and lipid composition.
    Leiss O; Murawski U; Egge H
    Scand J Clin Lab Invest Suppl; 1978; 150():77-84. PubMed ID: 218279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.